Using the Australian Immunisation Register (AIR)

AIR due and overdue rules for older Australians for respiratory syncytial virus (RSV) and pneumococcal

The AIR has introduced new ‘due’ and ‘overdue’ rules to support recent NIP changes. The rules will apply to the following cohorts: 

  • RSV rules: 
    • Aboriginal and Torres Strait Islander people aged 60 years and over  
    • people aged 75 years and over. 
  • Pneumococcal rules: 
    • Aboriginal and Torres Strait Islander people aged 25 years and over 
    • adults 65 years and over. 

Note: Adults who have previously received a pneumococcal vaccination (i.e. Prevenar 13 and Pneumovax 23) will appear as ‘due’ in the AIR for a 21-valent pneumococcal conjugate vaccine (Capvaxive) 12 months after their most recent vaccination.

The new AIR due and overdue rules are available on the Services Australia’s website. 
 

Display of due information and reminder letters

Due information will display for vaccination providers in the AIR site and clinical information software (integrated with the AIR). 

An individual’s Immunisation History Statement will display when they are due for an RSV and/or pneumococcal vaccine, and a reminder letter will be sent if they become overdue.
 

Updates to live attenuated influenza vaccine (FluMist)

Approximately 50% of FluMist administrations have been reported incorrectly to the AIR as ‘NIP/Commonwealth’ via the ‘Vaccine type’ field. 

As FluMist is only funded through state and territory programs or purchased privately, these administrations should be reported as ‘Other’. 

To address this: 

  • The AIR was updated on 15 June 2026 to prevent vaccination providers from selecting ‘NIP/Commonwealth’ when reporting FluMist administrations. 
  • Services Australia is retrospectively updating all existing FluMist records in the AIR to ensure they are correctly recorded as ‘Other’.

View additional AIR Tips and Updates here

Disclaimer: This information has been collated by staff members of the PHN Immunisation Support Program – an initiative of the National Centre for Immunisation Research and Surveillance. Care is taken to provide accurate information at the time of creation. However, users are responsible for checking the currency of this information. Once printed, this document is no longer quality-controlled. Content is considered correct as at 2 July 2026.

Last updated July 2026